RXRX Competitors & Alternatives
Compare Recursion Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
RXRX
Main Stock$4.03
Tradestie Score
32
Market Cap
$2.23B
Revenue Growth
-0.6%
Analyst Upside
+79.3%
Top Competitors
233 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ARQT
Arcutis Biotherapeutics, Inc. Common Stock
|
$25.17
|
$2.37B | 120.1 | 55 | Compare |
|
APGE
Apogee Therapeutics, Inc. Common Stock
|
$135.07
|
$2.35B | - | 54 | Compare |
|
IBRX
ImmunityBio, Inc. Common Stock
|
$10.14
|
$2.34B | - | 30 | Compare |
|
IRON
Disc Medicine, Inc. Common Stock
|
$64.27
|
$2.33B | - | 55 | Compare |
|
AGIO
Agios Pharmaceuticals, Inc.
|
$31.97
|
$2.33B | - | 53 | Compare |
|
GLPG
Galapagos NV
|
$27.73
|
$2.31B | 5.1 | 47 | Compare |
|
ADPT
Adaptive Biotechnologies Corporation Common Stock
|
$27.94
|
$2.22B | - | 50 | Compare |
|
TVTX
Travere Therapeutics, Inc. Common Stock
|
$56.84
|
$2.21B | - | 58 | Compare |
|
DNLI
Denali Therapeutics Inc. Common Stock
|
$20.02
|
$2.18B | - | 65 | Compare |
|
MESO
Mesoblast Limited American Depositary Shares
|
$14.07
|
$2.08B | - | 53 | Compare |
More RXRX Analysis
Data updated: Oct 02, 2026 | Industry: Biotechnology (SIC 2836)
233 stocks in this industry